Benchmarking prophylaxis with factor concentrates: reference data on annualized bleeding rates in children with severe hemophilia
Authors:
Open Access
- 28 August 2025
- journal article
- Published by Ferrata Storti Foundation (Haematologica) in Haematologica
- Vol. 111 (2) , 733-737
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Hemophilia A and B: molecular and clinical similarities and differencesHaematologica, 2019
- Haemophilia B is clinically less severe than haemophilia A: further evidence2018
- Clinical, instrumental, serological and histological findings suggest that hemophilia B may be less severe than hemophilia AHaematologica, 2015
- The History of HemophiliaSeminars in Thrombosis and Hemostasis, 2014
- Prospective observational cohort studies for studying rare diseases: the European PedNet Haemophilia RegistryHaemophilia, 2014
- Intermediate-dose versus high-dose prophylaxis for severe hemophilia: comparing outcome and costs since the 1970sBlood, 2013
- Prophylaxis versus Episodic Treatment to Prevent Joint Disease in Boys with Severe HemophiliaNew England Journal of Medicine, 2007
- The effects of postponing prophylactic treatment on long-term outcome in patients with severe hemophiliaBlood, 2002
- Changes in treatment strategies for severe haemophilia over the last 3 decades: effects on clotting factor consumption and arthropathyHaemophilia, 2001
- Twenty‐five years' experience of prophylactic treatment in severe haemophilia A and BJournal of Internal Medicine, 1992